RSI News

Announcements & Updates

USC appoints Dr. Mattison distinguished professor

March 16, 2021

Dr. Donald Mattison, RSI’s Senior Vice-President and Chief Medical Officer, has accepted an appointment as a University of South Carolina Health Sciences Distinguished Professor in the in the Arnold School of Public Health (ASPH).  The appointment noted that Dr. Mattison’s broad and deep career experience as a researcher and educator is impressive and…

Read More

RSI receives National Defence funding

March 5, 2021

RSI is pleased to be the recipient of funding through the DND IDEaS COVID-19 Challenge. Under the supervision of Emma Hartnett, RSI will be developing a risk-based tool to support public health emergency response planning for COVID-19, and other infectious disease and mass casualty emergencies in the future. The safety…

Read More

Willhite receives prestigious SOT award

December 18, 2020

Calvin C. Willhite, an Associate Expert with Risk Sciences International working on a range of toxicological risk issues, was just announced as the recipient of the prestigious 2021 Arnold Lehman Award presented annually by the Society of Toxicology for outstanding contributions to evidence-based toxicology to improve public health. Dr. Willhite specializes in human…

Read More

RSI gives keynote

October 31, 2020

RSI experts Jennifer Go and Daniel Krewski, were recently invited to present a paper on maternal and child environmental heath during a global, virtual workshop originating in Foshan, Guangdong, China.

Read More

RSI hosts Mitacs intern

September 7, 2020

Risk Sciences International will host Abdallah Alami as an intern in statistics with support from the Mitacs Accelerate program. This unique university-industry program supports interns at Canadian companies while completing graduate their training at Canadian universities.    Mr. Alami will be completing his MSc in statistics at Carleton University under the supervision…

Read More

Dr. Mattison chairs NAM report

July 24, 2020

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the increasing focus on evidence based treatment the use of compounded medications substantially decreased.  However, in some therapeutic areas, such as menopause, use of compounded medications…

Read More

COVID-19 timeline by RSI

May 23, 2020

As part of its new Risk & Crisis Communication Master Class & Boot Camp, and its ongoing commitment to keep its understanding of major public health issues current, RSI has produced a COVID-19 Timeline with emphasis on Canada and the United States, communication and citizen oriented milestones, and official pronouncements…

Read More

Country Foods Forum

March 1, 2020

Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods Forum. The event attracted a number of experts in country foods risk assessment from across Canada. Participants and speakers represented a broad cross section of…

Read More

Workshop on Evidence Integration December 5-6, 2019

November 11, 2019

Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa and the Center for Alternatives to Animal Testing at Johns Hopkins University. The meeting will…

Read More
Special announcements sign-up

Stay informed

Click here if you would like to sign up to receive occasional updates from RSI
(max. four times a year).